The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of transfusion independence with improved overall survival in myelofibrosis patients receiving momelotinib.
 
Ruben A. Mesa
Honoraria - Abbvie; AOP Orphan Pharmaceuticals; BMS; Geron; Novartis; shire; Sierra Oncology
Consulting or Advisory Role - Baxalta; Galena Biopharma; Incyte; Novartis
Research Funding - Abbvie (Inst); Celgene (Inst); CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Imago Pharma (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis; Pharmaessentia
 
Stephen T. Oh
Consulting or Advisory Role - Blueprint Medicines; Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Disc Medicine; Incyte; Kartos Therapeutics; Novartis; PharmaEssentia
Research Funding - Blueprint Medicines (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Gilead Sciences (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Sierra Oncology (Inst)
 
Aaron Thomas Gerds
Consulting or Advisory Role - AstraZeneca/MedImmune; CTI; Incyte; Kartos Therapeutics; Promedior
Research Funding - Celgene; CTI; Gilead Sciences; Incyte; Pfizer; Roche/Genentech
 
Vikas Gupta
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; Novartis; Sierra Oncology
Consulting or Advisory Role - Celgene; Novartis; Roche; Sierra Oncology
Research Funding - Novartis (Inst)
 
John V. Catalano
Travel, Accommodations, Expenses - Celgene
 
Francisco Cervantes
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene; Novartis
 
Timothy Devos
No Relationships to Disclose
 
Marek Hus
No Relationships to Disclose
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Abbvie; AOP Orphan Pharmaceuticals; BMS; Incyte; Novartis; Pharmaessentia
 
Ewa Lech-Maranda
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Gilead Sciences; Janssen-Cilag; Novartis; Roche; Sanofi/Aventis; Takeda
 
Donal P. Mclornan
Speakers' Bureau - Celgene; Jazz Pharmaceuticals; Novartis
 
Jeanne Palmer
No Relationships to Disclose
 
Uwe Platzbecker
Honoraria - Celgene/Jazz
Consulting or Advisory Role - Celgene/Jazz
Research Funding - Amgen (Inst); BerGenBio (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - part of a patent for a TFR-2 antibody (Rauner et al. Nature Metabolics 2019)
Travel, Accommodations, Expenses - Celgene
 
Jacek Treliński
Consulting or Advisory Role - Amgen; Baxalta; Novartis; Novo Nordisk; Roche; SOBI; Takeda
 
Kazuya Shimoda
Speakers' Bureau - Celgene; Novartis; Takeda
 
Rafe Donahue
Employment - Sierra Oncology
Stock and Other Ownership Interests - Sierra Oncology
 
Bryan Strouse
Employment - Sierra Oncology
Stock and Other Ownership Interests - Sierra Oncology
 
Mark Marion Kowalski
Employment - Sierra Oncology
Stock and Other Ownership Interests - Sierra Oncology
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Sierra Oncology
Research Funding - Blueprint Medicines; Celgene; CTI BioPharma Corp; Genentech; Gilead Sciences; Incyte; Novartis; NS Pharma; Promedior; Roche